XENE Xenon: Nilai bisnis marang pendapatan

Logo perusahaan publik xenon-pharma.com (XENE)

Geopolitical instability is limiting capital inflows into risky biotechnology, yet the success of Xenon Pharmaceuticals (XENE) depends solely on clinical trials. The GURU.Markets portal features a chart of the company's price-to-sales ratio, where the value remains around 0.00. This price action confirms the strategy of expanding the epilepsy drug portfolio prior to market entry following the final phase of trials.

Multiplikator EV/Sales Xenon Pharmaceuticals Inc (XENE): kanggo periode 23.11.2025 - 20.11.2026

xenon-pharma.com - rincian analitis lan metrik utama (XENE)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
- informasi babagan dhuwit lan arus kas:
Pambiji fundamental:XENE - Xenon
Produk asil prodhuksi Xenon Pharmaceuticals

This indicator reflects the Enterprise Value of the entire business relative to revenue, excluding the impact of debt load to determine the real market valuation of assets. By analyzing changes in EV/Sales, an investor can assess the speculative gap in the valuation of Xenon Pharmaceuticals (XENE), where business stability depends directly on the success of XEN1101 clinical trials and the molecule's ability to obtain FDA certification.

Pesaing langsung

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales VKTX|Multiplikator EV/Sales supernus.com (SUPN)|Rasio nilai perusahaan marang pendapatan Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Nilai perusahaan marang volume dodolan|Harmony Corp - Multiplikator EV/Sales|BHVN: Rasio nilai perusahaan marang pendapatan|AMLX: Multiplikator EV/Sales|TRVI: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Praxis Medicines|Multiplikator nilai perusahaan marang pendapatan Anavex AVXL|Rasio nilai perusahaan marang pendapatan CeriBell Corp (CBLL)|Koefisien nilai perusahaan marang pendapatan PRTA|Multiplikator EV/Sales ALEC (Alector)|Annexon (ANNX) - Multiplikator nilai perusahaan marang pendapatan|OMER - Rasio nilai perusahaan marang pendapatan|NGNE (Neurogene) - Rasio nilai perusahaan marang pendapatan|ACIU: Multiplikator EV/Sales|VYGR - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Neumora Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan SCLX (Scilex)|Nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Multiplikator EV/Sales Alpha Cognition Inc (ACOG)|Multiplikator EV/Sales CGTX (cogrx.com)|Rasio total nilai perusahaan marang pendapatan Inhibikase Pharma (IKT)|SAVA: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Assertio ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan VTGN|OVID (Ovid Therapeutics) - Multiplikator EV/Sales|Acumen Pharmaceuticals, Inc (ABOS) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE